Search
for

    Sort by

    Research 331–360 of 351

    1. ZALCITABINE 2004
    2. TRANSPLANTE CAPILAR COM EXTRAÇÃO DE UNIDADE FOLICULAR: CUIDADOS DIRECIONADOS AOS EVENTOS ESPERADOS E COMPLICAÇÕES PÓS-OPERATÓRIAS Revista fisio&terapia. · 2025
    3. A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome Cancer · 1986 · 24 citations
    4. Pseudoglucagonoma syndrome secondary to pancreatitis: A case report Journal of Dr. YSR University of Health Sciences. · 2015 · 2 citations
    5. Pseudoglucagonoma Syndrome Following Frey’s Surgery: A Case Report of a Rare Presentation Curēus · 2024
    6. Persistent Hypoglycemia and Macrosomia in a Newborn Pediatrics in Review · 2026
    7. Necrolytic Migratory Erythema in a Cat with Glucagonoma Syndrome Acta Scientiae Veterinariae · 2017
    8. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression Human Reproduction Update · 2018 · 189 citations
    9. Dendrobium officinale polysaccharide improves hair regrowth in androgenetic alopecia mice and is associated with coordinated changes in local steroid metabolism, ESR1 activation, and keratin-related follicular responses Frontiers in Pharmacology · 2026
    10. Impact of yoga Nidra on psychological variables in women with polycystic ovarian syndrome International journal of yogic, human movement and sports sciences · 2024
    11. Efectos de la disminución de los depósitos tisulares de hierro sobre los factores de riesgo cardiovascular en pacientes con hiperandrogenismo ovárico funcional e_Buah · 2023
    12. Impending central retinal vein occlusion and granulomatous uveitis in a patient with Satoyoshi syndrome Medicine · 2023 · 1 citations
    13. The Lipid Profiles in Different Characteristics of Women with PCOS and the Interaction Between Dyslipidemia and Metabolic Disorder States: A Retrospective Study in Chinese Population Frontiers in Endocrinology · 2022 · 91 citations
    14. An N-Ethyl-N-Nitrosourea Induced Corticotropin-Releasing Hormone Promoter Mutation Provides a Mouse Model for Endogenous Glucocorticoid Excess Endocrinology · 2013 · 27 citations
    15. Lack of classic histology should not prevent diagnosis of necrolytic acral erythema Journal of the American Academy of Dermatology · 2008 · 16 citations
    16. Comparative Analysis of Differential Metabolites in <i>Panax quinquefolius</i> From China and the United States Using UPLC‐Orbitrap‐MS and LC‐MS/MS Food Safety and Health · 2025
    17. Polycystic Ovary Syndrome and Eating Disorders—A Literature Review Journal of Clinical Medicine · 2024
    18. Is polymorphism of the STK11 gene a predictor of response to metformin in polycystic ovarian syndrome? Authorea (Authorea) · 2024
    19. Relationship between Copper, Zinc, and Copper-to-Zinc Ratio in Hair and Severity of Coronary Artery Disease according to the SYNTAX Score Biology · 2023
    20. STUDY OF FECAL GLUCOCORTICOID METABOLITE IN BEARS: A REVIEW Malaysian Journal of Science. Series B, Physical & Earth Sciences · 2023
    21. Are STK11 polymorphisms a predictor of the response to metformin in polycystic ovarian syndrome? Biomedical reports · 2022
    22. Glucagon-like peptide-1 receptor agonist medications and hair loss: A retrospective cohort study Journal of the American Academy of Dermatology · 2025 · 31 citations
    23. Glucagon-Like Peptide-1 Receptor Agonists and Hair Loss: Current Evidence and Potential Mechanisms JAAD reviews. · 2026
    24. The Role of Glucagon-Like Peptide-1 Receptor Agonists in Hair Loss: Clinical Evidence and Proposed Mechanisms Dermatologic Surgery · 2026
    25. Effects of Glucagon-like Peptide-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes Journal of Clinical Medicine · 2026
    26. Increased Incidence and Risk of Hair Loss with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Multicentre Cohort Study EMJ Dermatology · 2025
    27. Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review Cureus · 2025
    28. Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review Cureus · 2025
    29. Risk of Alopecia Areata with Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss medRxiv (Cold Spring Harbor Laboratory) · 2025
    30. Abstract 4142154: Risk of Suicide, Hair Loss, and Aspiration with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Pharmacovigilance Study from the FAERS database Circulation · 2024